Address: GLOBAL BUSINESS & CONVENTION CENTRE
MEZZANINE FLOOR, BLOCK A,
NO. 8, JALAN 19/1, SECTION 19,
46300 PETALING JAYA
SELANGOR DARUL EHSAN
MALAYSIA
Tel: +603-7931 9003
The Malaysian Organisation of Pharmaceutical Industries (MOPI) was incorporated on March 6th 1981, as a company limited by guarantee, by eight local, foreign and joint venture companies involved in the manufacture of pharmaceutical products.
The MOPI membership collectively produces about 35% of Malaysia’s medicine requirements. In terms of product range, MOPI members have the capability to manufacture more than 80% of the product categories in the National Essential Drugs List of Malaysia.
MOPI, in co-operation with the government and other bodies, represents the interests of the pharmaceutical industry.
Promotion and development of the pharmaceutical industry.
Foster closer co-operation among members of the Industry.
Facilitate and encourage the development, exchange and transfer of information and technology, domestically and internationally.
Promote and facilitate orderly trade in life science products.
The pharmaceutical industry has been targeted as one of the key growth sectors for the Malaysian economy under the 10th Malaysia Plan, how successful in your opinion have the government…
The biggest pharma stories from Southeast Asia, including GSK’s new HPF manufacturing investment, license suspensions for Samco Farma and Ciubros Farma after Indonesia’s acute kidney injury crisis, Kalbe’s Aventis share…
Eurasia Group’s Aditya Bhattacharji discusses the relatively modest scope of Malaysia’s recently-launched ‘MYSalam’ scheme; a healthcare programme which aims to provide coverage to the country’s bottom 40 percent of earners.…
After 61 years of single-party rule, the May 2018 electoral victory of the populist Pakatan Harapan (PH) coalition sent shockwaves through the Malaysian political landscape. This has been keenly felt…
Click here to download the Healthcare & Life Sciences Review Malaysia 2018. After recent elections conducted in May 2018 saw Mahathir Mohamad returning as Prime Minister after 15 years to…
American medtech giant Baxter and pan-Asian healthcare service provider Zuellig Pharma have been collaborating in Malaysia to increase the quality and quantity of care that can be given to patients…
Sherene Azli, CEO of the Malaysia Healthcare Travel Council (MHTC), introduces this unique organization in charge of promoting Malaysia internationally as the ‘Cardiology and Fertility Hub of Asia’ and explains…
Rashidah Ibrahim, executive director of Malaysian Vaccines & Pharmaceuticals (MVP), tells the story of MVP as the sole animal vaccines manufacturer in Malaysia. She also explains how important animal health…
Chuwn Leong Ch’ng, CEO of Thunder Print, presents his company’s strategic role within the Malaysian healthcare industry to provide a high-quality packaging services for all type of health products, from…
Robert Kruit, chief executive for Zuellig Malaysia and Brunei, discusses Zuellig’s plans to expand beyond distribution and diversify its offering in the healthcare sector, and how Zuellig’s investments into digital…
Tan Sri Dato’ Ariffin Yusuf, founder and managing director of Primabumi, explains how he came to build Primabumi in 1975 and how he managed to position the company as a…
Halal pharmaceuticals – medicines that do not contain any alcohol, parts of animals such as dogs, pigs, bees, or any other substances prohibited as ‘haram’ under Shariah law – are…
Lee Yee Keng, head of healthcare sector of KPMG in Malaysia, highlights the opportunities Malaysia can offer to the healthcare industry, including its potential for private-public partnerships, and how the…
See our Cookie Privacy Policy Here
